Your browser doesn't support javascript.
loading
Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India.
Behera, Priyamadhaba; Singh, Arvind Kumar; Subba, Sonu Hangma; Mc, Arjun; Sahu, Dinesh Prasad; Chandanshive, Pradnya Dilip; Pradhan, Somen Kumar; Parida, Swayam Pragyan; Mishra, Abhisek; Patro, Binod Kumar; Batmanabane, Gitanjali.
Afiliación
  • Behera P; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Singh AK; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Subba SH; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Mc A; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Sahu DP; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Chandanshive PD; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Pradhan SK; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Parida SP; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Mishra A; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Patro BK; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
  • Batmanabane G; All India Institute of Medical Sciences, Bhubaneswar, India.
Hum Vaccin Immunother ; 18(1): 2034456, 2022 12 31.
Article en En | MEDLINE | ID: mdl-35321625
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Hum Vaccin Immunother Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Hum Vaccin Immunother Año: 2022 Tipo del documento: Article